Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Clinical features associated with costs in early AD: baseline data from the Predictors Study.

Zhu CW, Scarmeas N, Torgan R, Albert M, Brandt J, Blacker D, Sano M, Stern Y.

Neurology. 2006 Apr 11;66(7):1021-8.

PMID:
16606913
2.

Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease.

Zhu CW, Scarmeas N, Torgan R, Albert M, Brandt J, Blacker D, Sano M, Stern Y.

Neurology. 2006 Sep 26;67(6):998-1005. Epub 2006 Aug 16.

PMID:
16914696
3.

The incremental direct costs associated with behavioral symptoms in AD.

Murman DL, Chen Q, Powell MC, Kuo SB, Bradley CJ, Colenda CC.

Neurology. 2002 Dec 10;59(11):1721-9.

PMID:
12473759
4.

The impact of parkinsonism on costs of care in patients with AD and dementia with Lewy bodies.

Murman DL, Kuo SB, Powell MC, Colenda CC.

Neurology. 2003 Oct 14;61(7):944-9.

PMID:
14557565
5.

Cost and care of patients with Alzheimer's disease: clinical predictors in German health care settings.

Reese JP, Hessmann P, Seeberg G, Henkel D, Hirzmann P, Rieke J, Baum E, Dannhoff F, Müller MJ, Jessen F, Geldsetzer MB, Dodel R.

J Alzheimers Dis. 2011;27(4):723-36. doi: 10.3233/JAD-2011-110539.

PMID:
21876256
6.

The impact of symptom severity on the cost of Alzheimer's disease.

Small GW, McDonnell DD, Brooks RL, Papadopoulos G.

J Am Geriatr Soc. 2002 Feb;50(2):321-7.

PMID:
12028215
7.

Cognitive function and the costs of Alzheimer disease. An exploratory study.

Ernst RL, Hay JW, Fenn C, Tinklenberg J, Yesavage JA.

Arch Neurol. 1997 Jun;54(6):687-93.

PMID:
9193203
8.

Determinants of costs of care for patients with Alzheimer's disease.

Jönsson L, Eriksdotter Jönhagen M, Kilander L, Soininen H, Hallikainen M, Waldemar G, Nygaard H, Andreasen N, Winblad B, Wimo A.

Int J Geriatr Psychiatry. 2006 May;21(5):449-59.

PMID:
16676288
9.

[Costs of health care resources of ambulatory-care patients diagnosed with Alzheimer's disease in Spain].

Boada M, Peña-Casanova J, Bermejo F, Guillén F, Hart WM, Espinosa C, Rovira J.

Med Clin (Barc). 1999 Nov 27;113(18):690-5. Spanish.

PMID:
10650570
10.

The economic benefits of acetylcholinesterase inhibitors for patients with Alzheimer disease and associated dementias.

Fillit H, Hill J.

Alzheimer Dis Assoc Disord. 2004 Apr-Jun;18 Suppl 1:S24-9.

PMID:
15249845
11.

Health service utilization among Alzheimer's disease patients: evidence from managed care.

Frytak JR, Henk HJ, Zhao Y, Bowman L, Flynn JA, Nelson M.

Alzheimers Dement. 2008 Sep;4(5):361-7. doi: 10.1016/j.jalz.2008.02.007. Epub 2008 Apr 21.

PMID:
18790463
12.

Clinical characteristics and longitudinal changes of informal cost of Alzheimer's disease in the community.

Zhu CW, Scarmeas N, Torgan R, Albert M, Brandt J, Blacker D, Sano M, Stern Y.

J Am Geriatr Soc. 2006 Oct;54(10):1596-602.

13.

The pharmacoeconomics of Alzheimer's disease.

Fillit HM.

Am J Manag Care. 2000 Dec;6(22 Suppl):S1139-44; discussion S1145-8. Review.

14.

The economic impact of dementia in Belgium: results of the National Dementia Economic Study (NADES).

Scuvee-Moreau J, Kurz X, Dresse A; National Dementia Economic Study Group.

Acta Neurol Belg. 2002 Sep;102(3):104-13.

15.

The effects of patient function and dependence on costs of care in Alzheimer's disease.

Zhu CW, Leibman C, McLaughlin T, Scarmeas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y.

J Am Geriatr Soc. 2008 Aug;56(8):1497-503. doi: 10.1111/j.1532-5415.2008.01798.x. Epub 2008 Jul 24.

16.

Costs and quality of life of multiple sclerosis in Switzerland.

Kobelt G, Berg J, Lindgren P, Gerfin A, Lutz J.

Eur J Health Econ. 2006 Sep;7 Suppl 2:S86-95.

PMID:
17310338
17.

Modeling the influence of extrapyramidal signs on the progression of Alzheimer disease.

Stern Y, Liu X, Albert M, Brandt J, Jacobs DM, Del Castillo-Castaneda C, Marder K, Bell K, Sano M, Bylsma F.

Arch Neurol. 1996 Nov;53(11):1121-6.

PMID:
8912485
18.

Evaluated need, costs of care, and payer perspective in degenerative dementia patients cared for in the United States.

Murman DL, Von Eye A, Sherwood PR, Liang J, Colenda CC.

Alzheimer Dis Assoc Disord. 2007 Jan-Mar;21(1):39-48.

PMID:
17334271
19.

Alzheimer disease: diagnosis, costs, and dimensions of treatment.

DeKosky ST, Orgogozo JM.

Alzheimer Dis Assoc Disord. 2001 Aug;15 Suppl 1:S3-7.

PMID:
11669507
20.

Economic considerations in Alzheimer's disease.

Meek PD, McKeithan K, Schumock GT.

Pharmacotherapy. 1998 Mar-Apr;18(2 Pt 2):68-73; discussion 79-82. Review.

PMID:
9543467

Supplemental Content

Support Center